InterCure Ltd. (INCR)
InterCure Statistics
Share Statistics
InterCure has 47.16M shares outstanding. The number of shares has increased by 3.49% in one year.
| Shares Outstanding | 47.16M |
| Shares Change (YoY) | 3.49% |
| Shares Change (QoQ) | 3.05% |
| Owned by Institutions (%) | 5.25% |
| Shares Floating | 27.16M |
| Failed to Deliver (FTD) Shares | 17 |
| FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 27.92K, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 27.92K |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.1% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -3.44 and the forward PE ratio is null. InterCure's PEG ratio is 0.01.
| PE Ratio | -3.44 |
| Forward PE | n/a |
| PS Ratio | 0.6 |
| Forward PS | 0.1 |
| PB Ratio | 0.47 |
| P/FCF Ratio | -3.79 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for InterCure.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.85 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | -8.19 |
| Debt / FCF | -3.48 |
| Interest Coverage | -1.72 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $1.32M |
| Profits Per Employee | $-229.48K |
| Employee Count | 270 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.36 |
Taxes
| Income Tax | 2.25M |
| Effective Tax Rate | -3.67% |
Stock Price Statistics
The stock price has increased by -44.3% in the last 52 weeks. The beta is 0.49, so InterCure's price volatility has been higher than the market average.
| Beta | 0.49 |
| 52-Week Price Change | -44.3% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.74 |
| Relative Strength Index (RSI) | 41.59 |
| Average Volume (20 Days) | 21.17K |
Income Statement
In the last 12 months, InterCure had revenue of 355.55M and earned -61.96M in profits. Earnings per share was -1.36.
| Revenue | 355.55M |
| Gross Profit | 105.09M |
| Operating Income | -41.57M |
| Net Income | -61.96M |
| EBITDA | -23.9M |
| EBIT | -37.07M |
| Earnings Per Share (EPS) | -1.36 |
Balance Sheet
The company has 101.14M in cash and 195.68M in debt, giving a net cash position of -94.54M.
| Cash & Cash Equivalents | 101.14M |
| Total Debt | 195.68M |
| Net Cash | -94.54M |
| Retained Earnings | -204M |
| Total Assets | 740.89M |
| Working Capital | 161.94M |
Cash Flow
In the last 12 months, operating cash flow was -53.63M and capital expenditures -2.62M, giving a free cash flow of -56.25M.
| Operating Cash Flow | -53.63M |
| Capital Expenditures | -2.62M |
| Free Cash Flow | -56.25M |
| FCF Per Share | -1.23 |
Margins
Gross margin is 29.56%, with operating and profit margins of -11.69% and -17.43%.
| Gross Margin | 29.56% |
| Operating Margin | -11.69% |
| Pretax Margin | -17.24% |
| Profit Margin | -17.43% |
| EBITDA Margin | -6.72% |
| EBIT Margin | -11.69% |
| FCF Margin | -15.82% |
Dividends & Yields
INCR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for INCR.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Apr 8, 2021. It was a backward split with a ratio of 1:4.
| Last Split Date | Apr 8, 2021 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | 0.36 |
| Piotroski F-Score | 3 |